Amfexa and Spinal Numbness
Spinal numbness is not a recognized or documented side effect of Amfexa (dextroamphetamine), and this symptom should prompt immediate evaluation for alternative neurological causes rather than being attributed to the medication.
Evidence Base
The available evidence does not support a causal relationship between dextroamphetamine and spinal numbness:
Known Side Effects of Dextroamphetamine
According to established practice parameters 1, the documented adverse effects of dextroamphetamine include:
- Common mild effects: Sleep onset delay, reduced appetite, stomachache, headache, jitteriness
- Less common: Motor tics, mood disturbances, irritability, anxiety
- Rare: Cognitive impairment, perseverative behaviors, psychosis, hallucinosis
- Cardiovascular: Blood pressure elevation, tachycardia 2, 3
Notably absent from this comprehensive list is any mention of numbness, paresthesias, or spinal symptoms.
Neurological Effects Are Central, Not Peripheral
The one relevant study examining amphetamine's spinal effects 4 investigated noradrenergic mechanisms in the spinal cord related to reflex facilitation—this is a pharmacological mechanism study, not a clinical adverse effect. Amphetamine's actions are centrally mediated through dopamine and norepinephrine pathways in the brain, not through direct spinal nerve effects that would cause numbness.
Dermal vs. Neurological Effects
Recent transdermal dextroamphetamine studies 5 documented only local skin irritation at application sites, not systemic neurological symptoms like numbness. This further confirms that peripheral sensory symptoms are not characteristic of amphetamine therapy.
Clinical Approach
If a patient on Amfexa reports spinal numbness, you must:
Do not attribute this to the medication - this is not a known side effect
Evaluate urgently for serious neurological conditions:
- Spinal cord compression (tumor, abscess, herniated disc)
- Transverse myelitis
- Multiple sclerosis
- Spinal stroke
- Vitamin B12 deficiency with subacute combined degeneration
- Peripheral neuropathy from other causes
Obtain immediate neurological examination focusing on:
- Sensory level determination
- Motor strength testing
- Reflexes and pathological signs
- Bladder/bowel function
- Gait assessment
Consider urgent MRI of the spine if examination suggests myelopathy
Important Caveat
While muscle pain and stiffness have been reported with methylphenidate (a different stimulant) 6, this is distinct from numbness and involves a different medication class. Do not confuse muscle pain with sensory numbness—these are fundamentally different symptoms requiring different evaluations.
The cardiovascular monitoring recommended for dextroamphetamine 1 (blood pressure, pulse) does not include neurological assessments because neurological adverse effects like spinal numbness are not part of the expected side effect profile.
Bottom line: Spinal numbness in a patient taking Amfexa is a red flag for serious neurological pathology, not a medication side effect. Investigate accordingly.